Syngenta Makes a Killing on Pesticides While Feds Snooze

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


The pesticide atrazine is vile stuff. A “potent endocrine disruptor,” it causes a range of reproductive problems at extremely low doses; and it commonly leaches out of farm fields and into people’s drinking water. Unfortunately, it’s quite popular with industrial-scale corn growers, who apply about 70 million pounds of it per year to kill weeds.

Just this month, USDA researchers released a study finding that atrazine is even more volatile than they previously expected: It’s highly prone to evaporate after it’s applied, entering the air and eventually groundwater. That might explain why in towns throughout the Corn Belt, atrazine levels in drinking water tend to “spike” during the spring application season, as a 2009 New York Times investigation found.

A wise society might be expected to ban it. Citing its tendency to taint water, the European Union did just that in 2003. But that same year, atrazine’s maker, the Swiss chemical giant Syngenta, convinced our own EPA to maintain approval for it. To make its case, the company presented a bunch of studies it had funded that that have since been discredited. The EPA changed course in 2009, announcing it formally would review its decision to green light the toxic chemical. The review was initially slated to take a year; so far, nothing has come of it. An EPA press officer told me via email that the agency’s scientific-advisory panel charged with scrutinizing atrazine will meet this week. But it will be “upwards of 90 days” before any report is issued.

While the EPA undertakes its leisurely reconsideration, atrazine use is booming. It remains “one of the most widely used agricultural pesticides in the US” by the EPA’s own reckoning. And Syngenta recently reported a 14 percent jump in profits for the first half of 2011, based in part on “strong sales of atrazine” in North America.

The company attributed atrazine’s robust sales performance to “increased corn acreage” in the US Midwest—an example of how our government’s ethanol boosterism helps sell agrichemicals and degrades the environment. But there’s likely another factor at work here, too: the accelerating problem of “superweeds” resistant to the Roundup herbicide peddled by Syngenta’s rival, Monsanto, which I wrote about last week. Syngenta is explicitly marketing atrazine as a remedy for Roundup-resistant weeds. Funnily enough, Monsanto, too, is reporting robust sales of Roundup as farmers ramp up doses to try to fight back resistant weeds. By ushering farmers on to such pesticide treadmills, the the agrichemical industry turns failure into market opportunity.

Which leads us back to the question of whether the EPA, when its review is finally completed, will allow Syngenta to maintain its lucrative but hazardous herbicide on the market. As a jaded observer of the US regulatory system’s oversight of the agrichemical industry, I fear that it probably will.

Consider other recent decisions. The USDA explicitly acknowledges the superweed problem, but has in effect given up regulating Roundup Ready products altogether. And the EPA—as I reported earlier this year—has ignored the concerns of government scientists and continued to allow another European agribiz player, Bayer, to keep marketing another dodgy pesticide. This one, clothianidin, also widely used on our vast corn crop from pests, appears to seriously harm honeybee populations.

In short, our regulatory agencies seem incapable of placing the public interest over the prerogatives of agribusiness.

WE'LL BE BLUNT:

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't find elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

WE'LL BE BLUNT

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate